Literature DB >> 28562422

Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.

Menno Pruijm1, Yimin Lu, Fatma Megdiche, Maciej Piskunowicz, Bastien Milani, Matthias Stuber, Matthias Bachtler, Bruno Vogt, Michel Burnier, Andreas Pasch.   

Abstract

BACKGROUND: Arterial calcifications increase arterial stiffness and are associated with a faster decline of kidney function in patients with arterial hypertension (AH) and/or chronic kidney disease (CKD). Yet the underlying mechanisms linking arterial calcifications, vascular stiffness and renal function decline are incompletely understood. A novel in-vitro blood test evaluates the propensity of patient's serum to prevent the formation of calcifications by measuring the maturation time of calciprotein particles (CPP) [transformation time of amorphous calcium phosphate-containing primary CPP to crystalline hydroxyapatite-containing secondary CPP (T50)]. We hypothesized that a high arterial stiffness and a high propensity to calcify may be associated with high renal vascular resistance and low renal tissue oxygenation.
METHODS: T50 was measured in patients with AH and a preserved renal function, in CKD patients and in healthy controls, a lower T50 indicating a higher risk of calcification. Pulse wave velocity (PWV) was assessed as a measure of arterial stiffness, and renal resistive index was measured by renal Doppler ultrasound. Renal tissue oxygenation was measured by blood oxygenation level-dependent MRI using the mean R2 values of the cortex, the medulla and layers of renal parenchyma. A high R2 value corresponds to a low tissue oxygenation.
RESULTS: Mean T50 was 246 ± 129 min in 58 CKD patients, 275 ± 111 min in 48 AH patients and 324 ± 96 min in 39 healthy controls (Panova = 0.008). In multivariable adjusted linear regression analysis, serum T50 correlated negatively with circulating calcium and phosphate levels, mean cortical and medullary R2, PWV, renal resistive index and being hypertensive. PWV was positively associated with R2 levels of outer and inner layers of renal parenchyma.
CONCLUSION: The current study shows that hypertensive patients with preserved renal function as well as CKD patients have a higher risk of calcification than controls. High arterial stiffness and calcification propensity are linked to low renal tissue oxygenation and perfusion in hypertensive and CKD patients. These results provide new insights on the relationships among arterial stiffness, renal tissue oxygenation and the risk of developing CKD.

Entities:  

Mesh:

Year:  2017        PMID: 28562422     DOI: 10.1097/HJH.0000000000001406

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

Review 1.  Renal intraparenchymal resistive index: the ultrasonographic answer to many clinical questions.

Authors:  Pierpaolo Di Nicolò; Antonio Granata
Journal:  J Nephrol       Date:  2018-12-11       Impact factor: 3.902

2.  Serum Calcification Propensity T50 Associates with Disease Severity in Patients with Pseudoxanthoma Elasticum.

Authors:  Lukas Nollet; Matthias Van Gils; Suzanne Fischer; Laurence Campens; Swapna Karthik; Andreas Pasch; Julie De Zaeytijd; Bart P Leroy; Daniel Devos; Tine De Backer; Paul J Coucke; Olivier M Vanakker
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

3.  Serum Calcification Propensity and Clinical Events in CKD.

Authors:  Joshua D Bundy; Xuan Cai; Rupal C Mehta; Julia J Scialla; Ian H de Boer; Chi-Yuan Hsu; Alan S Go; Mirela A Dobre; Jing Chen; Panduranga S Rao; Mary B Leonard; James P Lash; Geoffrey A Block; Raymond R Townsend; Harold I Feldman; Edward R Smith; Andreas Pasch; Tamara Isakova
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-28       Impact factor: 8.237

4.  Calcium Phosphate Bions Cause Intimal Hyperplasia in Intact Aortas of Normolipidemic Rats through Endothelial Injury.

Authors:  Daria Shishkova; Elena Velikanova; Maxim Sinitsky; Anna Tsepokina; Olga Gruzdeva; Leo Bogdanov; Anton Kutikhin
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

Review 5.  Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease.

Authors:  Ciprian N Silaghi; Tamás Ilyés; Adriana J Van Ballegooijen; Alexandra M Crăciun
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

6.  Calciprotein Particles Cause Endothelial Dysfunction under Flow.

Authors:  Daria Shishkova; Victoria Markova; Maxim Sinitsky; Anna Tsepokina; Elena Velikanova; Leo Bogdanov; Tatiana Glushkova; Anton Kutikhin
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 7.  Phosphate, Calcification in Blood, and Mineral Stress: The Physiologic Blood Mineral Buffering System and Its Association with Cardiovascular Risk.

Authors:  Andreas Pasch; Willi Jahnen-Dechent; Edward R Smith
Journal:  Int J Nephrol       Date:  2018-09-02

8.  Fibroblast growth factor 23 expression in human calcified vascular tissues.

Authors:  Javier Donate-Correa; Ernesto Martín-Núñez; Carolina Hernández-Carballo; Carla Ferri; Víctor G Tagua; Alejandro Delgado-Molinos; Ángel López-Castillo; Sergio Rodríguez-Ramos; Purificación Cerro-López; Victoria Castro López-Tarruella; Raquel Felipe-García; Miguel A Arévalo-Gomez; Nayra Pérez-Delgado; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  Aging (Albany NY)       Date:  2019-09-22       Impact factor: 5.682

9.  Calciprotein Particles: Balancing Mineral Homeostasis and Vascular Pathology.

Authors:  Anton G Kutikhin; Lian Feenstra; Alexander E Kostyunin; Arseniy E Yuzhalin; Jan-Luuk Hillebrands; Guido Krenning
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-11       Impact factor: 8.311

10.  Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus.

Authors:  Rik Mencke; Amarens van der Vaart; Andreas Pasch; Geert Harms; Femke Waanders; Henk J G Bilo; Harry van Goor; Jan-Luuk Hillebrands; Peter R van Dijk
Journal:  BMJ Open Diabetes Res Care       Date:  2021-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.